Atai advances oral psychedelic in depression
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: research
Opinion: Aspirin after a broken bone: health equity in a $5 bottle
There are few things more exciting for researchers than to mount and complete a clinical…
A tough week for MDMA-assisted psychotherapy
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more
If you twirl a bottle of alcohol and squint, you might see a text box…
Three MDMA therapy papers retracted over data integrity concerns
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels…
Opinion: Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a…
Morning Rounds: Another Ebola outbreak?
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Why did Novo pull heart failure paperwork for Wegovy?
Hey, humans. Today, we talk about the decades-long pursuit to get MDMA approved as a…
How experiencing famine in the womb may shape people’s health as adults
Hunger killed an estimated 4 million people in Ukraine between 1932 and 1933 — the…
STAT+: A strong start for Madrigal’s MASH drug launch
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Scientists are starting to uncover how neighborhood can affect the biology of cancer
Where you live has a relationship to your odds of getting cancer and surviving cancer….
A new drug for glioma means a windfall for Agios
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
The exclusive biotech stories you need to read
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Congress is unprepared for the post-Chevron world. It needs help from subject matter experts
The U.S. Congress needs help. It lacks the expertise to do its job in the…
Opinion: Cost-effectiveness of health interventions may be perpetuating health disparities. Here’s how to fix that
As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized…
FDA ad comm favors Zevra’s Niemann-Pick drug
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Diversity statements should not be required for federal STEMM grant funding
Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel…
Opinion: The coronavirus lab leak hypothesis is damaging science
Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 —…
Moderna is still in a Covid hangover
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: ACL tears in women: Too many injuries and too little research
Some of the world’s finest athletes were sidelined by a torn anterior cruciate ligament (the…
STAT+: On Andrew Left and the government’s fraud case
I love the Summer Olympics. Every four years I transform into a huge fan of…
venBio raises $528 million for its fifth fund
Want to stay on top of the science and politics driving biotech today? Sign up to get…
With Biden’s departure in sight, advocates seek to preserve gains of Cancer Moonshot
In President Biden’s address to the nation after dropping out of the election race, he…
Morning Rounds: Grindr gets into health care lobbying
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
The debate over how long to use Alzheimer’s drugs
Good morning. We have a new investigation out today about how Mount Sinai in New…
STAT+: Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research
Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes…
Testing GLP-1s in Alzheimer’s, and is Medicare a good negotiator?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
There’s more data for trans people with HIV than any other disease — but it’s still flawed
Transgender people are at higher-than-average risk of contracting HIV. And yet, when epidemiologist Diana Tordoff…
STAT+: Parasite engineered to treat brain development disorder in mice shows potential in study
The human body works hard to prevent outside substances from entering the brain — which…
New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns
If up to half of Americans no longer qualify for a statin or a blood…
The biotech news you need from the weekend
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The worst for Dexcom may not be over
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How Kamala Harris’ views on health care were shaped by her mother, cancer researcher Shyamala Gopalan
As Vice President Kamala Harris emerges as the likely Democratic candidate in the U.S. presidential…
Breast cancer study reveals a paradox of mastectomy
Breast cancer surgeons have tended not to push patients towards bilateral mastectomy, since data have…
STAT+: A preview of Neurocrine’s muscarinic drug readout
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
A potential rival for Wegovy and Zepbound enters the fray
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Merck lays off workers amid rough pharma job market
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Contradictory coverage decisions in North Carolina
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Four health care and biotech updates to stay on top of this week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: The newest tool to prevent STIs is not available to everyone: A call for participatory and inclusive research
In the midst of an “out of control” epidemic of sexually transmitted infections (STIs) in…
Novo, Lilly shares sink due to concerns over competition
Hellloooooo. Today, we discuss the FDA’s lack of engagement with critics of MDMA for PTSD…
Opinion: The ‘Risky Research Review Act’ would do more harm than good
In an era of rapid scientific and technological advances when politicians and scientists are struggling…
Massive study of veterans’ DNA shows how diversity can help researchers decipher the genome
An expansive new study offers clear evidence that sequencing the genomes of diverse populations can…
‘Legal’ psychedelic mushrooms actually contain illegal hallucinogens, study shows
WASHINGTON – A new study published Thursday finds that several mushroom candies, which are widely…
STAT+: Novartis not ready to admit a $3 billion mistake
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
The biotech news stories you need to know today
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Broad Institute, facing end of Microsoft cloud contract, shuffles data science leadership
The Broad Institute of MIT and Harvard is perhaps best known for the trailblazing work…
Opinion: IRBs fail to assess trials’ scientific merit, putting participants at risk
Thousands of people volunteer for clinical research trials in the United States every year. They…
Bone marrow donors needn’t be perfect match, study says, paving way for more equitable access
As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect…